What Is a Bosniak Cyst? Current Classification and Treatment Approach

The Bosniak cyst classification is a systematic framework for assessing cystic kidney lesions in terms of malignancy (cancer) risk. Distinguishing kidney cysts in modern medicine is crucial for protecting patients from unnecessary surgery and ensuring timely diagnosis in high-risk cases. First described by Dr. Morton Bosniak in 1986, this classification underwent a major revision in 2019, expanding to include both CT (computed tomography) and MRI (magnetic resonance imaging) criteria. Recent clinical studies have provided important data on the malignant potential of Bosniak class III and IV cysts, follow-up duration and the reliability of active surveillance strategies. This article will answer questions such as what a Bosniak cyst is, what its classes are, how it is diagnosed and what current management approaches involve, in detail using scientific and current sources.

Definition and Historical Development of Bosniak Cysts

The Bosniak classification divides kidney cysts into five main classes according to their anatomical and radiological characteristics. This system has been updated alongside the evolution of imaging technologies and has become a strong framework for guiding clinical decision algorithms.

Although the original definition in 1986 was based only on contrast-enhanced CT imaging, it has evolved to accommodate newer modalities such as MRI and contrast-enhanced ultrasound (CEUS). With the 2019 publication of the Bosniak v2019 update, assessment criteria were defined more clearly, interdisciplinary differences in interpretation were reduced and new recommendations were introduced, particularly for lesions requiring follow-up (IIF).

These advances have improved diagnostic accuracy and reduced the rate of overtreatment.

What Are the Bosniak Classes? Definitions According to Current 2025 Guidelines

The Bosniak classification divides cystic renal lesions into 5 main groups according to malignancy risk:

Classes I, II, IIF (requiring follow-up), III and IV.

Classification is based on the lesion’s wall thickness, internal structure, contrast enhancement and presence or absence of solid components. Each class is explained in detail below.

Bosniak Class I: Simple, Benign Cysts

• Lesions with thin, smooth walls containing only fluid.
• They do not show contrast enhancement.
• There is no malignancy risk.
• They generally develop with age and require no treatment.

Bosniak Class II: Mildly Complex Cysts

• May contain 1–2 thin septa and mild calcification.
• The fluid is homogeneous and does not enhance with contrast.
• Cancer risk is below 1%.
• No follow-up is needed.

Bosniak Class IIF: Cysts Requiring Follow-Up

• May contain more septa, mild wall thickening and minimal irregularities.
• Mild contrast enhancement may occur.
• Malignancy risk ranges from 5–15%.
• Imaging once a year for 5 years is recommended for follow-up.

Bosniak Class III: Suspicious Cysts

• Marked wall thickening, irregular septa and marked contrast enhancement are seen.
• Malignancy risk ranges from 50–80%.
• Surgical evaluation is generally recommended, but active surveillance may also be considered for low-volume, small masses (≤2 cm).

Bosniak Class IV: Cysts With the Highest Suspicion of Malignancy

• In addition to class III features, they contain solid components or nodules.
• All these structures enhance with contrast.
• Cancer risk ranges from 85–100%.
• Treatment is usually surgical.

How Are Bosniak Cysts Diagnosed? The Most Effective Imaging Methods

Bosniak classification is generally performed using contrast-enhanced computed tomography (CT) . However, in recent years, newer techniques such as magnetic resonance imaging (MRI) and contrast-enhanced ultrasound (CEUS) have also been used effectively in diagnosis.

CT (Computed Tomography)

• The gold standard for classification.
• Contrast-enhanced CT can identify septa, calcifications and nodules.

MRI (Magnetic Resonance Imaging)

• More sensitive in distinguishing soft tissues.
• Offers performance similar to CT in assessing contrast enhancement.

CEUS (Contrast-Enhanced Ultrasound)

• Used particularly in the follow-up of class IIF and class III cysts.
• Involves no radiation.
• Available at a limited number of centers.

Malignancy Risk in Bosniak Cysts and Its Clinical Significance

Current data show the average malignancy risk for each class as follows:

Treatment must therefore be planned very carefully, particularly for class III and IV cysts.

What Are the Treatment Options for Bosniak Cysts?

Surveillance (Follow-Up)

• Preferred for class I, II and IIF cysts.
• For class IIF, follow-up for 5 years with imaging every 6 months or annually is recommended.

Surgery

• Recommended for class III and IV cysts.
• Partial nephrectomy (removal of part of the kidney) is generally preferred.
• Depending on the tumor’s location and size, radical nephrectomy (removal of the entire kidney) may also be considered.

Ablative Treatments (Local Destruction Methods)

• The cyst contents are destroyed using laser, radiofrequency or cryoablation methods.
• Generally used in patients who are unsuitable for surgery or are elderly.

What Does the Current Literature Say?

• A systematic review published in 2023 found that only 4.6% of Bosniak class IIF cysts progressed over time, while most remained stable.
• A retrospective study conducted in 2025 showed that class III cysts measuring ≤2 cm had a low rate of progression to cancer and could be managed with surveillance.
• New imaging algorithms and AI-assisted analyses are reducing differences in interpretation and improving diagnostic accuracy in Bosniak classification.

Conclusion: When Are Bosniak Cysts Dangerous, and When Can You Remain Calm?

The Bosniak classification is an effective scientific tool for determining the seriousness of kidney cysts. While class I and II lesions generally require no treatment, class III and IV cysts require closer monitoring or intervention. Recent studies in particular suggest that active surveillance may be a safe and effective option in many cases . However, each patient must be assessed individually according to cyst characteristics.